Clinical trial

Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of…

NCT00409344 · Massachusetts General Hospital, Other · Terminated

Key facts

NCT number NCT00409344
Title Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
Official title Phase 4 Study of Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms
Lead sponsor Massachusetts General Hospital, Other
Collaborators Hospira, now a wholly owned subsidiary of Pfizer Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Sedation, Respiration, Artificial, Length of Stay
Intervention type Drug, Other
Interventions Dexmedetomidine, Normal Saline
Enrollment 0
Start date Jan 1, 2007
Primary completion Jan 1, 2008
Completion Jan 1, 2008
First posted Dec 8, 2006
Last update posted Sep 22, 2009
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies